FDA Weakens Rules on Testing New Drugs_LA Times
FDA is speeding the testing of unknown, potentially toxic products in humans (Phase I trials) without adequate pre-human tests.
Psych drug Rx for teens surge 250% over seven years_Brandeis
A Brandeis University study reviewed clinical practice (doctor office visits) and found that drug prescriptions for the treatment of depression, anxiety and mood or attention disorders in teenagers (14 to 18) increased by 250% between 1994-2001.
FDA rules aim to speed drug tests and trim costs
The Food and Drug Administration yesterday issued new guidelines that make it easier for scientists working in universities and small companies to test promising therapies in humans without matching the hefty spending of large drug companies.
ACNP Task Force Ties to Pharma
Authors of the American College of Neuropsychopharmacology Task Force on SSRIs and Suicidal Behavior in Youth: their known ties to the pharmaceutical industry
Unhealthy Medicine-Wash Post_Drug Profits Infect Medical Studies–LA Times
”SO WHY,” he asks, “DID American doctors prescribe $7 billion worth of Vioxx after Merck and the Food and Drug Administration knew all this?”
FDA: NIMH SSRI Study Flawed–No Comparative Untreated Group
Even Dr. Robet Temple, FDA Medical Policy Director of the Center for Drug Evaluation & Research dismisses the claimed finidings of a flawed, but highly trumpeted recent SSRI study published in the American Journal of Psychiatry. The study was sponsored by the National Institute of Mental Health.
J & J Failed to Disclose Deaths in Heart Trial
"When you’re talking deaths in clinical trials, mistakes are not an option," said Dr. Arthur Caplan, a medical ethicist at the University of Pennsylvania. "It’s just an area where we have to have absolute, foolproof reporting in place."
Pharma front ACSH: “Whiny Whistleblower of the Year Award”
2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films.
FDA SSRI Warning
" A causal role for antidepressants in inducing suicidality has been established in pediatric patients."
PhRMA-“The Karasik Conspiracy”–100 E-mails
The year 2005 will surely be the year in which the pharmaceutical industry’s
dirty tricks and underhanded tactics were revealed for what they are–a
menace to society.
NIMH-funded antidepression drug efficacy / safety studies_What do they prove?
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
National Plan for Universal Mental Health Screening:A Pharma Friendly Remedy for Societal Problems
Download the complete powerpoint presentation
Text of power point presentation:
Slide 2: I’ll begin with the President’s New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness – 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.